Hepatitis C virus drugs that inhibit SARS-CoV-2 papain-like protease synergize with remdesivir to suppress viral replication in cell culture

Effective control of COVID-19 requires antivirals directed against SARS-CoV-2. We assessed 10 hepatitis C virus (HCV) protease-inhibitor drugs as potential SARS-CoV-2 antivirals. There is a striking structural similarity of the substrate binding clefts of SARS-CoV-2 main protease (M(pro)) and HCV NS...

Descripción completa

Detalles Bibliográficos
Autores principales: Bafna, Khushboo, White, Kris, Harish, Balasubramanian, Rosales, Romel, Ramelot, Theresa A., Acton, Thomas B., Moreno, Elena, Kehrer, Thomas, Miorin, Lisa, Royer, Catherine A., García-Sastre, Adolfo, Krug, Robert M., Montelione, Gaetano T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8075848/
https://www.ncbi.nlm.nih.gov/pubmed/33984267
http://dx.doi.org/10.1016/j.celrep.2021.109133

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8075848/
https://www.ncbi.nlm.nih.gov/pubmed/33984267
http://dx.doi.org/10.1016/j.celrep.2021.109133

Ejemplares similares